ATE359068T1 - Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen - Google Patents

Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen

Info

Publication number
ATE359068T1
ATE359068T1 AT00948900T AT00948900T ATE359068T1 AT E359068 T1 ATE359068 T1 AT E359068T1 AT 00948900 T AT00948900 T AT 00948900T AT 00948900 T AT00948900 T AT 00948900T AT E359068 T1 ATE359068 T1 AT E359068T1
Authority
AT
Austria
Prior art keywords
compound
hot flashes
treating
patient
subunit
Prior art date
Application number
AT00948900T
Other languages
English (en)
Inventor
Thomas J Guttoso Jr
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Application granted granted Critical
Publication of ATE359068T1 publication Critical patent/ATE359068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AT00948900T 1999-07-22 2000-07-21 Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen ATE359068T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14506199P 1999-07-22 1999-07-22

Publications (1)

Publication Number Publication Date
ATE359068T1 true ATE359068T1 (de) 2007-05-15

Family

ID=22511431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948900T ATE359068T1 (de) 1999-07-22 2000-07-21 Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen

Country Status (12)

Country Link
US (1) US6310098B1 (de)
EP (1) EP1202725B1 (de)
AT (1) ATE359068T1 (de)
AU (1) AU767119B2 (de)
CA (1) CA2378918C (de)
CY (1) CY1107623T1 (de)
DE (1) DE60034344T2 (de)
DK (1) DK1202725T3 (de)
ES (1) ES2287021T3 (de)
NZ (1) NZ517044A (de)
PT (1) PT1202725E (de)
WO (1) WO2001007037A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) * 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
US20080207755A1 (en) * 2000-05-31 2008-08-28 Pfizer Inc Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
SI1423168T1 (sl) * 2001-09-03 2006-06-30 Newron Pharm Spa Farmacevtski sestavek, ki vsebuje gabapentin ali njegov analog in alfa-aminoamid, in njegova analgetska uporaba
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
EP1575501A2 (de) * 2002-07-12 2005-09-21 University of Rochester VERWENDUNG VON AMINOSûUREN ZUR BEHANDLUNG VERSCHIEDENER ERKRANKUNGEN
NZ537521A (en) * 2002-08-14 2007-05-31 Pharmacia & Upjohn Co Llc Use of reboxetine for the treatment of hot flashes
CN101862317A (zh) * 2002-12-13 2010-10-20 沃尼尔·朗伯有限责任公司 用于治疗纤维肌痛和其它疾病的普加巴林衍生物
MXPA05010515A (es) 2003-03-31 2006-03-10 Xenoport Inc Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
KR20060119971A (ko) * 2003-09-11 2006-11-24 제노포트 인코포레이티드 Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
WO2005027850A2 (en) * 2003-09-17 2005-03-31 Xenoport, Inc. Treating or preventing restless legs syndrome using prodrugs of gaba analogs
MXPA06004088A (es) * 2003-10-14 2006-06-27 Xenoport Inc Forma cristalina de un analogo del acido gamma-aminobutirico.
EP1811986B1 (de) 2004-11-04 2014-03-26 XenoPort, Inc. Orale darreichungsformen von gabapentin-prodrug mit verzögerter freisetzung
EP1963280B1 (de) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylaminoderivate als calcium- und/oder natrium-kanalmodulatoren
EP1976503A2 (de) * 2005-12-29 2008-10-08 Depomed, Inc. Magenretentive gabapentin-dosierformen und anwendungsverfahren
US20090176882A1 (en) * 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
US8329750B2 (en) * 2008-02-11 2012-12-11 Depomed, Inc. Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
CN102223893B (zh) 2008-07-22 2014-07-16 曼诺吉尼克斯公司 治疗与绝经、激素改变和关节炎相关的症状的组合物和方法
US9151289B2 (en) 2008-08-21 2015-10-06 Cummins Inc. Fuel pump
ES2574210T3 (es) * 2010-03-02 2016-06-15 Fervent Pharmaceuticals, Llc Métodos y composiciones para tratar o prevenir los síntomas de las variaciones hormonales
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
EP3484456A4 (de) 2016-07-17 2020-03-18 Mapi Pharma Limited Retard-darreichungsformen von pregabalin
EP3958862A4 (de) * 2019-04-22 2023-01-25 Robert L. Knobler Hormonfreie behandlung von hitzewallungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
GB9308430D0 (en) * 1993-04-23 1993-06-09 Glaxo Group Ltd Medicaments
SK282848B6 (sk) 1996-03-14 2002-12-03 Warner-Lambert Company Premostené cyklické aminokyseliny, farmaceutická kompozícia obsahujúca tieto aminokyseliny
HRP980342A2 (en) 1997-06-25 1999-02-28 Warner Lambert Co Anti-inflammatory method
AU8668598A (en) 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
US5962505A (en) 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
AU3735000A (en) * 1999-05-05 2000-11-21 Warner-Lambert Company Modulation of substance p by gaba analogs and methods relating thereto

Also Published As

Publication number Publication date
EP1202725B1 (de) 2007-04-11
DE60034344T2 (de) 2008-01-10
CA2378918A1 (en) 2001-02-01
CY1107623T1 (el) 2013-03-13
WO2001007037A1 (en) 2001-02-01
EP1202725A4 (de) 2004-02-04
PT1202725E (pt) 2007-07-11
AU767119B2 (en) 2003-10-30
ES2287021T3 (es) 2007-12-16
AU6233000A (en) 2001-02-13
US6310098B1 (en) 2001-10-30
DE60034344D1 (de) 2007-05-24
DK1202725T3 (da) 2007-07-23
NZ517044A (en) 2004-02-27
CA2378918C (en) 2007-01-23
EP1202725A1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
DE60034344D1 (de) Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
CY1105199T1 (el) Θepαπευτικες συνθεσεις για αντιμετωπιση της υπepεκκρισης βλεννας
BR9509807A (pt) Composição líquida para administração oral e processo para tratar um mamífero incluindo o homem que esteja sofrendo de um quadro clinico mediado pela aç o do 5ht nos receptores 5ht3
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BR0211122A (pt) Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
DE602004017481D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
DE69926804D1 (de) Vorrichtungen zur behandlung und diagnose des restless leg syndroms
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
DK1255569T3 (da) Pax2 til behandling af nyresygdomme
BRPI0409151A (pt) uso de derivados de 10-hidróxi-10,11-diidrocarbamazepina para o tratamento de transtornos afetivos
BR0203267A (pt) Combinações farmacêuticas para o tratamento de doenças neurodegenerativas
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
SE8903529D0 (sv) Medical use
DK0762883T3 (da) Pyridylbisphosphonater til anvendelse som terapeutisk middel
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE60129562D1 (de) Methode zur behandlung von hitzewallungen, durch verwendung eines tachikinin-rezeptor antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1202725

Country of ref document: EP